Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BrainScope closes late-stage equity round

Executive Summary

In what appears to be its Series C round, BrainScope Co. Inc. (neurotechnology devices) raised $16mm from new backer DBL Partners (which added a member to the BrainScope board) and existing investors Revolution LLC, ZG Ventures, and Maryland Venture Fund. The company will use the proceeds to support the launch of its FDA-approved BrainScope One (also known as Ahead 300), an EEG-based point-of-care device to rapidly evaluate and diagnose a mild head injury (up to three days post injury, using brain electrical activity and a patient’s neurocognitive function), as well as for continued R&D activities for additional technologies to objectively assess various other neurological conditions.
Deal Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies